Identifying the Respiratory Manifestations of TK2d: The Pulmonologist’s Role
May 14, 2026 - 00:14:45
Radio and PodcastLive Radio & PodcastsHealth
Advancing MS Care with Multimodal Aging Signatures and Proteomic Biomarkers
Guest: Adil Harroud, MD Guest: Dylan Hamitouche Host: Ryan Quigley Multimodal aging signatures are reshaping our understanding of progression and prognosis in multiple sclerosis (MS). Host Ryan Quigley sits down with Dr....
About This Episode
Advancing MS Care with Multimodal Aging Signatures and Proteomic Biomarkers is an episode from NeuroFrontiers by ReachMD. Guest: Adil Harroud, MD Guest: Dylan Hamitouche Host: Ryan Quigley Multimodal aging signatures are reshaping our under...
Podcast
This episode belongs to NeuroFrontiers.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Feb 19, 2026, 00:10:45 long, audio available.
Related Episodes
Continue listening to more episodes from NeuroFrontiers.
Recognizing TK2d: Key Clinical Signs and Diagnostic Protocols
May 14, 2026 - 00:13:30
Understanding Variability in Myasthenia Gravis
May 1, 2026 - 00:03:45
Examining the Global Genetic Prevalence of TK2d
Apr 30, 2026 - 00:14:01
Advances in Cell-Based Therapy for MS
Apr 20, 2026 - 00:03:15
Next-Generation MS Care: The Promise of Cell-Based Therapeutics
Apr 20, 2026 - 00:03:00
Applying the 2024 McDonald Criteria: Real-World Impacts on MS Diagnosis
Mar 30, 2026 - 00:03:00
Proactive Pregnancy Planning and Reproductive Care in MS
Mar 30, 2026 - 00:03:00
Questions About This Episode
What is Advancing MS Care with Multimodal Aging Signatures and Proteomic Biomarkers about?
Guest: Adil Harroud, MD Guest: Dylan Hamitouche Host: Ryan Quigley Multimodal aging signatures are reshaping our understanding of progression and prognosis in multiple sclerosis (MS). Host Ryan Quigley sits down with Dr. Adil Harroud and Mr. Dylan Hamitouche to learn more about implications for the future of risk stratification and personalized treatment in MS, a topic they presented on at the 2026 ACTRIMS Forum. Dr. Harroud is a neurologist and the co-leader of the Neuroimmunology Diseases Research Group at the Montreal Neurological Institute at McGill University. Mr. Hamitouche is a medical student at McGill University.
Where can I listen to Advancing MS Care with Multimodal Aging Signatures and Proteomic Biomarkers?
You can listen to Advancing MS Care with Multimodal Aging Signatures and Proteomic Biomarkers online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is Advancing MS Care with Multimodal Aging Signatures and Proteomic Biomarkers from?
Advancing MS Care with Multimodal Aging Signatures and Proteomic Biomarkers is an episode from NeuroFrontiers by ReachMD.
How long is this episode?
This episode is 00:10:45 long.
When was this episode published?
This episode was published on Feb 19, 2026.
Can I save Advancing MS Care with Multimodal Aging Signatures and Proteomic Biomarkers for later?
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Are there related episodes from NeuroFrontiers?
Yes. This page shows related episodes from NeuroFrontiers when more episodes are available from the podcast feed.
Quick Answers About This Episode
Where can I listen to Advancing MS Care with Multimodal Aging Signatures and Proteomic Biomarkers?
You can listen to Advancing MS Care with Multimodal Aging Signatures and Proteomic Biomarkers on this page when the episode audio is available from the podcast feed.
Which podcast is this episode from?
Advancing MS Care with Multimodal Aging Signatures and Proteomic Biomarkers is from NeuroFrontiers by ReachMD.
What are the episode details?
Published Feb 19, 2026 and 00:10:45 long